| Prev Close: | 1.58 |
|---|---|
| Open: | N/A |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 4.00 |
| Beta: | 1.56 |
| Next Earnings Date: | 17-Jul-13 |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 0.42 - 5.50 |
| Volume: | 0 |
| Avg Vol (3m): | 2,583,750 |
| Market Cap: | 216.63M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.29 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- FDA Green Light = Surprise Share Surgeat Motley Fool(Tue May 21)
- These Winners Couldn't Send the Dow to Another Recordat Motley Fool(Mon May 20)
- Biotech Companies: The FDA Doesn't Care About Your Phase 3 Trialsat Motley Fool(Mon May 20)
- Small-cap makes a splash with FDA nod for cancer drugat MarketWatch(Mon May 20)
- Movers roundup: WPX Energy, PeregrineAP(Mon May 20)
- Why Peregrine Pharmaceuticals Shares Skyrocketedat Motley Fool(Mon May 20)
- Peregrine rises on agreement for late-stage studyAP(Mon May 20)
- Apple Explores OLED For Its Smartwatch and 2 Other Hot Stocks to Watchat Wall St. Cheat Sheet(Mon May 20)
- Peregrine Pharma agrees with FDA on lung cancer trial designat Reuters(Mon May 20)
- PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Mon May 20)
- Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung CancerMarketwired(Mon May 20)
- Peregrine Pharmaceuticals' Immunotherapy Bavituximab to Be Highlighted in Three Clinical Data Presentations at 2013 ASCO Annual MeetingMarketwired(Thu May 16)
- StockCall Early Morning Insight into SQNM, PPHM, OPTR, ONXX, and INOAccesswire(Thu May 16)
- Osiris Loss In-Line with ExpectationsZacks(Wed May 8)
- PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Wed May 8)
Press Releases
- StockCall Early Morning Insight into SQNM, PPHM, OPTR, ONXX, and INOAccesswire(Thu May 16)
- Ubika Research’s Daily US Box Score: Top Junior Healthcare (NASDAQ: PPHM) Stock Gained 80%Accesswire(Tue Jan 8)
- Pre-Market Research On Most Active NASDAQ Stocks: (NASDAQ: PPHM), (NASDAQ: ACAD)Accesswire(Tue Dec 18)
Must Read
- These beaches have gone to the dogs; lucky pooches lap up the shoreline where they run freeThe Canadian Press(Wed May 22)
- HP's 2nd-qtr report shows signs of further decay but offers hope of recovery; stock soarsThe Canadian Press(Wed May 22)
- HP raises 2013 outlook as Whitman's plan takes holdReuters(Wed May 22)
- Clearwire, shareholders brace for fight over Sprint bidReuters(Wed May 22)
- First lady lauds preservation of slave quarters near White House as vital to 'national memory'The Canadian Press(Wed May 22)